|
|||||
![]() |
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter![]() |
Ticker | Owner | Relationship | Date | Transaction | Cost ![]() |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
SIGA | Hruby Dennis E | EVP & Chief Scientific Officer | Jul 01 '24 | Option Exercise | 0.00 | 32,258 | 0 | 179,723 | Jul 03 05:19 PM |
SIGA | Hruby Dennis E | VP & Chief Scientific Officer | Jan 03 '17 | Option Exercise | 0.00 | 25,000 | 0 | 176,824 | Jan 05 08:12 PM |
SIGA | Hruby Dennis E | VP & Chief Scientific Officer | Dec 08 '16 | Option Exercise | 0.00 | 50,000 | 0 | 172,124 | Dec 12 05:35 PM |
SIGA | Hruby Dennis E | VP & Chief Scientific Officer | Feb 28 '14 | Option Exercise | 0.00 | 25,000 | 0 | 96,133 | Mar 04 05:09 PM |
SIGA | Hruby Dennis E | VP & Chief Scientific Officer | Jan 03 '14 | Option Exercise | 0.00 | 25,000 | 0 | 81,545 | Jan 07 07:09 PM |
SIGA | Hruby Dennis E | VP & Chief Scientific Officer | Dec 17 '13 | Option Exercise | 1.40 | 150,000 | 210,000 | 165,747 | Dec 19 05:26 PM |
SIGA | Hruby Dennis E | VP & Chief Scientific Officer | Feb 28 '13 | Option Exercise | 0.00 | 25,000 | 0 | 25,000 | Mar 04 07:03 PM |
SIGA | Hruby Dennis E | Chief Scientific Officer | May 19 '11 | Option Exercise | 2.50 | 300,000 | 750,000 | 425,000 | May 23 04:43 PM |
SIGA | Hruby Dennis E | Chief Scientific Officer | May 19 '11 | Sale | 13.64 | 41,300 | 563,332 | 383,700 | May 23 04:43 PM |
SIGA | Hruby Dennis E | Chief Scientific Officer | May 20 '11 | Sale | 13.51 | 188,000 | 2,539,880 | 195,700 | May 23 04:43 PM |
SIGA | Hruby Dennis E | Chief Scientific Officer | May 23 '11 | Sale | 13.09 | 70,700 | 925,463 | 125,000 | May 23 04:43 PM |
SIGA | Hruby Dennis E | Chief Scientific Officer | Mar 29 '10 | Sale | 6.78 | 67,018 | 454,382 | 857,982 | Mar 31 05:12 PM |
SIGA | Hruby Dennis E | Chief Scientific Officer | Mar 30 '10 | Sale | 6.51 | 57,982 | 377,463 | 800,000 | Mar 31 05:12 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite